PharmaLight Overview

  • Founded
  • 2003
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Buyout/​LBO
  • Investors
  • 1

PharmaLight General Information

Description

Developer of an ocular drug delivery platform designed to offer ophthalmic drug delivery technologies. The company's platform safely and effectively increases ocular blood flow and administers therapeutics to the posterior segment of the eye, enabling healthcare providers to improve the lives of the patients and cure them.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Primary Office
  • 85 Medinat Hayehudim
  • Herzliya Pituach
  • Herzliya 46140
  • Israel
+972 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaLight Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Buyout/LBO 01-Jan-2010 Completed Startup
To view PharmaLight’s complete valuation and funding history, request access »

PharmaLight Executive Team (1)

Name Title Board Seat Contact Info
Marcelle Juliet Saul Sheiman Founder & Chief Executive Officer
To view PharmaLight’s complete executive team members history, request access »

PharmaLight Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PharmaLight Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Rainbow Medical Innovation Venture Capital Majority 000 0000 000000 0
To view PharmaLight’s complete investors history, request access »